-
Clostridium difficile infection in obstetrics and gynecology patients
Bogdan I. Stefanescu, Georgiana Bianca Constantin
Mini Review: Clinical Investigation
-
Clostridium difficile infection in obstetrics and gynecology patients
Bogdan I. Stefanescu, Georgiana Bianca Constantin
Mini Review: Clinical Investigation
-
Clostridium difficile infection in obstetrics and gynecology patients
Bogdan I. Stefanescu, Georgiana Bianca Constantin
Mini Review: Clinical Investigation
-
Clostridium difficile infection in obstetrics and gynecology patients
Bogdan I. Stefanescu, Georgiana Bianca Constantin
Mini Review: Clinical Investigation
-
Clostridium difficile infection in obstetrics and gynecology patients
Bogdan I. Stefanescu, Georgiana Bianca Constantin
Mini Review: Clinical Investigation
-
Clostridium difficile infection in obstetrics and gynecology patients
Bogdan I. Stefanescu, Georgiana Bianca Constantin
Mini Review: Clinical Investigation
-
Clostridium difficile infection in obstetrics and gynecology patients
Bogdan I. Stefanescu, Georgiana Bianca Constantin
Mini Review: Clinical Investigation
-
Clostridium difficile infection in obstetrics and gynecology patients
Bogdan I. Stefanescu, Georgiana Bianca Constantin
Mini Review: Clinical Investigation
-
Prescription Pattern Analysis of Antidiabetic Drugs in Diabetes Mellitus and Associated Comorbidities
Mohd Mahmood, Ronda Charitha Reddy, J R Soumya Lahari, Sadiya Fatima, Pooja Shinde, S Anand Reddy, Pranali S Pandit
Research Article: Clinical Investigation
-
Prescription Pattern Analysis of Antidiabetic Drugs in Diabetes Mellitus and Associated Comorbidities
Mohd Mahmood, Ronda Charitha Reddy, J R Soumya Lahari, Sadiya Fatima, Pooja Shinde, S Anand Reddy, Pranali S Pandit
Research Article: Clinical Investigation
-
Prescription Pattern Analysis of Antidiabetic Drugs in Diabetes Mellitus and Associated Comorbidities
Mohd Mahmood, Ronda Charitha Reddy, J R Soumya Lahari, Sadiya Fatima, Pooja Shinde, S Anand Reddy, Pranali S Pandit
Research Article: Clinical Investigation
-
Prescription Pattern Analysis of Antidiabetic Drugs in Diabetes Mellitus and Associated Comorbidities
Mohd Mahmood, Ronda Charitha Reddy, J R Soumya Lahari, Sadiya Fatima, Pooja Shinde, S Anand Reddy, Pranali S Pandit
Research Article: Clinical Investigation
-
Prescription Pattern Analysis of Antidiabetic Drugs in Diabetes Mellitus and Associated Comorbidities
Mohd Mahmood, Ronda Charitha Reddy, J R Soumya Lahari, Sadiya Fatima, Pooja Shinde, S Anand Reddy, Pranali S Pandit
Research Article: Clinical Investigation
-
Prescription Pattern Analysis of Antidiabetic Drugs in Diabetes Mellitus and Associated Comorbidities
Mohd Mahmood, Ronda Charitha Reddy, J R Soumya Lahari, Sadiya Fatima, Pooja Shinde, S Anand Reddy, Pranali S Pandit
Research Article: Clinical Investigation
-
Prescription Pattern Analysis of Antidiabetic Drugs in Diabetes Mellitus and Associated Comorbidities
Mohd Mahmood, Ronda Charitha Reddy, J R Soumya Lahari, Sadiya Fatima, Pooja Shinde, S Anand Reddy, Pranali S Pandit
Research Article: Clinical Investigation
-
Prescription Pattern Analysis of Antidiabetic Drugs in Diabetes Mellitus and Associated Comorbidities
Mohd Mahmood, Ronda Charitha Reddy, J R Soumya Lahari, Sadiya Fatima, Pooja Shinde, S Anand Reddy, Pranali S Pandit
Research Article: Clinical Investigation
-
Clinical rationale of sucroferric oxyhydroxide for controlling hyperphosphatemia in patients with chronic kidney disease
Stuart M Sprague, Morgan Marcuccilli & Viatcheslav Rakov
Drug Evaluation: Clinical Investigation
-
Clinical rationale of sucroferric oxyhydroxide for controlling hyperphosphatemia in patients with chronic kidney disease
Stuart M Sprague, Morgan Marcuccilli & Viatcheslav Rakov
Drug Evaluation: Clinical Investigation
-
Clinical rationale of sucroferric oxyhydroxide for controlling hyperphosphatemia in patients with chronic kidney disease
Stuart M Sprague, Morgan Marcuccilli & Viatcheslav Rakov
Drug Evaluation: Clinical Investigation
-
Clinical rationale of sucroferric oxyhydroxide for controlling hyperphosphatemia in patients with chronic kidney disease
Stuart M Sprague, Morgan Marcuccilli & Viatcheslav Rakov
Drug Evaluation: Clinical Investigation
-
Clinical rationale of sucroferric oxyhydroxide for controlling hyperphosphatemia in patients with chronic kidney disease
Stuart M Sprague, Morgan Marcuccilli & Viatcheslav Rakov
Drug Evaluation: Clinical Investigation
-
Clinical rationale of sucroferric oxyhydroxide for controlling hyperphosphatemia in patients with chronic kidney disease
Stuart M Sprague, Morgan Marcuccilli & Viatcheslav Rakov
Drug Evaluation: Clinical Investigation
-
Clinical rationale of sucroferric oxyhydroxide for controlling hyperphosphatemia in patients with chronic kidney disease
Stuart M Sprague, Morgan Marcuccilli & Viatcheslav Rakov
Drug Evaluation: Clinical Investigation
-
Clinical rationale of sucroferric oxyhydroxide for controlling hyperphosphatemia in patients with chronic kidney disease
Stuart M Sprague, Morgan Marcuccilli & Viatcheslav Rakov
Drug Evaluation: Clinical Investigation
-
Assessing health-related quality of life in cancer trials
Roxanne E Jensen, Carol M Moinpour, Diane L Fairclough
Clinical Trail Perspective: Clinical Investigation
-
Assessing health-related quality of life in cancer trials
Roxanne E Jensen, Carol M Moinpour, Diane L Fairclough
Clinical Trail Perspective: Clinical Investigation
-
Assessing health-related quality of life in cancer trials
Roxanne E Jensen, Carol M Moinpour, Diane L Fairclough
Clinical Trail Perspective: Clinical Investigation
-
Assessing health-related quality of life in cancer trials
Roxanne E Jensen, Carol M Moinpour, Diane L Fairclough
Clinical Trail Perspective: Clinical Investigation
-
Assessing health-related quality of life in cancer trials
Roxanne E Jensen, Carol M Moinpour, Diane L Fairclough
Clinical Trail Perspective: Clinical Investigation
-
Assessing health-related quality of life in cancer trials
Roxanne E Jensen, Carol M Moinpour, Diane L Fairclough
Clinical Trail Perspective: Clinical Investigation
-
Assessing health-related quality of life in cancer trials
Roxanne E Jensen, Carol M Moinpour, Diane L Fairclough
Clinical Trail Perspective: Clinical Investigation
-
Assessing health-related quality of life in cancer trials
Roxanne E Jensen, Carol M Moinpour, Diane L Fairclough
Clinical Trail Perspective: Clinical Investigation
-
The early clinical development of a multicomponent vaccine against meningococcal serogroup B
James Wassil
Review: Clinical Trail Outcomes: Clinical Investigation
-
The early clinical development of a multicomponent vaccine against meningococcal serogroup B
James Wassil
Review: Clinical Trail Outcomes: Clinical Investigation
-
The early clinical development of a multicomponent vaccine against meningococcal serogroup B
James Wassil
Review: Clinical Trail Outcomes: Clinical Investigation
-
The early clinical development of a multicomponent vaccine against meningococcal serogroup B
James Wassil
Review: Clinical Trail Outcomes: Clinical Investigation
-
The early clinical development of a multicomponent vaccine against meningococcal serogroup B
James Wassil
Review: Clinical Trail Outcomes: Clinical Investigation
-
The early clinical development of a multicomponent vaccine against meningococcal serogroup B
James Wassil
Review: Clinical Trail Outcomes: Clinical Investigation
-
The early clinical development of a multicomponent vaccine against meningococcal serogroup B
James Wassil
Review: Clinical Trail Outcomes: Clinical Investigation
-
The early clinical development of a multicomponent vaccine against meningococcal serogroup B
James Wassil
Review: Clinical Trail Outcomes: Clinical Investigation
-
Linagliptin tablets first to receive US FDA approval at one dosage strength for Type 2 diabetes treatment
News and Views: Clinical Investigation
-
Linagliptin tablets first to receive US FDA approval at one dosage strength for Type 2 diabetes treatment
News and Views: Clinical Investigation
-
Linagliptin tablets first to receive US FDA approval at one dosage strength for Type 2 diabetes treatment
News and Views: Clinical Investigation
-
Linagliptin tablets first to receive US FDA approval at one dosage strength for Type 2 diabetes treatment
News and Views: Clinical Investigation
-
Linagliptin tablets first to receive US FDA approval at one dosage strength for Type 2 diabetes treatment
News and Views: Clinical Investigation
-
Linagliptin tablets first to receive US FDA approval at one dosage strength for Type 2 diabetes treatment
News and Views: Clinical Investigation
-
Linagliptin tablets first to receive US FDA approval at one dosage strength for Type 2 diabetes treatment
News and Views: Clinical Investigation
-
Linagliptin tablets first to receive US FDA approval at one dosage strength for Type 2 diabetes treatment
News and Views: Clinical Investigation
-
Clinical trials of systemic therapy in osteosarcoma and Ewing\\\'s sarcoma: past, present and future
R Grant Rowe, Rashmi Chugh
Review Article: Clinical Investigation
-
Clinical trials of systemic therapy in osteosarcoma and Ewing\\\'s sarcoma: past, present and future
R Grant Rowe, Rashmi Chugh
Review Article: Clinical Investigation
-
Clinical trials of systemic therapy in osteosarcoma and Ewing\\\'s sarcoma: past, present and future
R Grant Rowe, Rashmi Chugh
Review Article: Clinical Investigation
-
Clinical trials of systemic therapy in osteosarcoma and Ewing\\\'s sarcoma: past, present and future
R Grant Rowe, Rashmi Chugh
Review Article: Clinical Investigation
-
Clinical trials of systemic therapy in osteosarcoma and Ewing\\\'s sarcoma: past, present and future
R Grant Rowe, Rashmi Chugh
Review Article: Clinical Investigation
-
Clinical trials of systemic therapy in osteosarcoma and Ewing\\\'s sarcoma: past, present and future
R Grant Rowe, Rashmi Chugh
Review Article: Clinical Investigation
-
Clinical trials of systemic therapy in osteosarcoma and Ewing\\\'s sarcoma: past, present and future
R Grant Rowe, Rashmi Chugh
Review Article: Clinical Investigation
-
Clinical trials of systemic therapy in osteosarcoma and Ewing\\\'s sarcoma: past, present and future
R Grant Rowe, Rashmi Chugh
Review Article: Clinical Investigation
-
y-secretase inhibitors for treating Alzheimer\\\'s disease: rationale and clinical data
Francesco Panza, Vincenza Frisardi, Bruno P Imbimbo, Davide Seripa, Vincenzo Solfrizzi, Alberto Pilotto
Review Article: Clinical Investigation
-
y-secretase inhibitors for treating Alzheimer\\\'s disease: rationale and clinical data
Francesco Panza, Vincenza Frisardi, Bruno P Imbimbo, Davide Seripa, Vincenzo Solfrizzi, Alberto Pilotto
Review Article: Clinical Investigation
-
y-secretase inhibitors for treating Alzheimer\\\'s disease: rationale and clinical data
Francesco Panza, Vincenza Frisardi, Bruno P Imbimbo, Davide Seripa, Vincenzo Solfrizzi, Alberto Pilotto
Review Article: Clinical Investigation
-
y-secretase inhibitors for treating Alzheimer\\\'s disease: rationale and clinical data
Francesco Panza, Vincenza Frisardi, Bruno P Imbimbo, Davide Seripa, Vincenzo Solfrizzi, Alberto Pilotto
Review Article: Clinical Investigation
-
y-secretase inhibitors for treating Alzheimer\\\'s disease: rationale and clinical data
Francesco Panza, Vincenza Frisardi, Bruno P Imbimbo, Davide Seripa, Vincenzo Solfrizzi, Alberto Pilotto
Review Article: Clinical Investigation
-
y-secretase inhibitors for treating Alzheimer\\\'s disease: rationale and clinical data
Francesco Panza, Vincenza Frisardi, Bruno P Imbimbo, Davide Seripa, Vincenzo Solfrizzi, Alberto Pilotto
Review Article: Clinical Investigation
-
y-secretase inhibitors for treating Alzheimer\\\'s disease: rationale and clinical data
Francesco Panza, Vincenza Frisardi, Bruno P Imbimbo, Davide Seripa, Vincenzo Solfrizzi, Alberto Pilotto
Review Article: Clinical Investigation
-
y-secretase inhibitors for treating Alzheimer\\\'s disease: rationale and clinical data
Francesco Panza, Vincenza Frisardi, Bruno P Imbimbo, Davide Seripa, Vincenzo Solfrizzi, Alberto Pilotto
Review Article: Clinical Investigation
-
Combination therapy for gastrointestinal stromal tumors: evidence from recent clinical trials
Isabelle Ray-Coquard, Philippe Cassier, Intidhar Labidi Galy, Pierre Heudel, Louis Tassy, Maria Chelghoum, Amandine Burghas, Pierre Meeus,Jean Yves Blay
Review Article: Clinical Investigation
-
Combination therapy for gastrointestinal stromal tumors: evidence from recent clinical trials
Isabelle Ray-Coquard, Philippe Cassier, Intidhar Labidi Galy, Pierre Heudel, Louis Tassy, Maria Chelghoum, Amandine Burghas, Pierre Meeus,Jean Yves Blay
Review Article: Clinical Investigation
-
Combination therapy for gastrointestinal stromal tumors: evidence from recent clinical trials
Isabelle Ray-Coquard, Philippe Cassier, Intidhar Labidi Galy, Pierre Heudel, Louis Tassy, Maria Chelghoum, Amandine Burghas, Pierre Meeus,Jean Yves Blay
Review Article: Clinical Investigation
-
Combination therapy for gastrointestinal stromal tumors: evidence from recent clinical trials
Isabelle Ray-Coquard, Philippe Cassier, Intidhar Labidi Galy, Pierre Heudel, Louis Tassy, Maria Chelghoum, Amandine Burghas, Pierre Meeus,Jean Yves Blay
Review Article: Clinical Investigation
-
Combination therapy for gastrointestinal stromal tumors: evidence from recent clinical trials
Isabelle Ray-Coquard, Philippe Cassier, Intidhar Labidi Galy, Pierre Heudel, Louis Tassy, Maria Chelghoum, Amandine Burghas, Pierre Meeus,Jean Yves Blay
Review Article: Clinical Investigation
-
Combination therapy for gastrointestinal stromal tumors: evidence from recent clinical trials
Isabelle Ray-Coquard, Philippe Cassier, Intidhar Labidi Galy, Pierre Heudel, Louis Tassy, Maria Chelghoum, Amandine Burghas, Pierre Meeus,Jean Yves Blay
Review Article: Clinical Investigation
-
Combination therapy for gastrointestinal stromal tumors: evidence from recent clinical trials
Isabelle Ray-Coquard, Philippe Cassier, Intidhar Labidi Galy, Pierre Heudel, Louis Tassy, Maria Chelghoum, Amandine Burghas, Pierre Meeus,Jean Yves Blay
Review Article: Clinical Investigation
-
Combination therapy for gastrointestinal stromal tumors: evidence from recent clinical trials
Isabelle Ray-Coquard, Philippe Cassier, Intidhar Labidi Galy, Pierre Heudel, Louis Tassy, Maria Chelghoum, Amandine Burghas, Pierre Meeus,Jean Yves Blay
Review Article: Clinical Investigation
-
Fixed combination therapies based on direct renin inhibition: a commentary to the ACCELERATE trial
Giuliano Tocci, Diana Chin, Massimo Volpe
Editorial: Clinical Investigation
-
Fixed combination therapies based on direct renin inhibition: a commentary to the ACCELERATE trial
Giuliano Tocci, Diana Chin, Massimo Volpe
Editorial: Clinical Investigation
-
Fixed combination therapies based on direct renin inhibition: a commentary to the ACCELERATE trial
Giuliano Tocci, Diana Chin, Massimo Volpe
Editorial: Clinical Investigation
-
Fixed combination therapies based on direct renin inhibition: a commentary to the ACCELERATE trial
Giuliano Tocci, Diana Chin, Massimo Volpe
Editorial: Clinical Investigation
-
Fixed combination therapies based on direct renin inhibition: a commentary to the ACCELERATE trial
Giuliano Tocci, Diana Chin, Massimo Volpe
Editorial: Clinical Investigation
-
Fixed combination therapies based on direct renin inhibition: a commentary to the ACCELERATE trial
Giuliano Tocci, Diana Chin, Massimo Volpe
Editorial: Clinical Investigation
-
Fixed combination therapies based on direct renin inhibition: a commentary to the ACCELERATE trial
Giuliano Tocci, Diana Chin, Massimo Volpe
Editorial: Clinical Investigation
-
Fixed combination therapies based on direct renin inhibition: a commentary to the ACCELERATE trial
Giuliano Tocci, Diana Chin, Massimo Volpe
Editorial: Clinical Investigation